[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 7, Issue 1 (Spring 2023) ::
Iran J Cult Health Promot 2023, 7(1): 68-74 Back to browse issues page
Pharmacist Intervention in Controlling Symptoms with Common Upper Respiratory Disease
Ghader Mohammadnezhad , Mostafa Jafari , Hadi Esmaily
Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran,
Abstract:   (485 Views)
Abstract
Background: The role of pharmacists in pharmacies has evolved from drug dispensers to more specialized tasks. The general purpose of this article is to analyze and investigate pharmacist intervention in controlling symptoms of outpatients suffering from common acute upper respiratory disease via prescription of non-prescription drugs according to the pharmaceutical rules and regulations in the health sector.
Methods: This is a clinical trial that was conducted on patients with one of the diseases of common cold, flu, acute rhino-sinusitis, laryngitis, or allergic rhinitis in community pharmacies with acute symptoms. The first group underwent diagnostic and therapeutic (theranostic) interventions by a pharmacist based on non-pharmacological treatment or, if necessary, non-prescription drugs. The second group received over-the-counter medicine based on their own request and without the pharmacist theranostic approach. Patient symptoms were evaluated before initiation of monitoring and then one week later.
Results: The results of the difference in average scores of 100 patients in five diseases for the intervention and non-intervention subgroups were 23.30 and 14.45 for common colds, 20.00 and 13.35 for influenza, 11.40 and 7.15 for allergic rhinitis, 15.00 and 14.00 for laryngitis, and 30.00 and 23.00 for sinusitis, respectively. The difference in clinical improvement scores in all diseases was significantly higher in the pharmacist intervention subgroup, except for patients with laryngitis, where no significant difference was observed between the two subgroups.
Conclusion: Pharmacists have the potential to control the symptoms of patients with common upper respiratory tract disease. Using this capacity in primary care can improve minor ailments.
Keywords: Minor ailments, Nonprescription Drugs, Outpatients, Primary Health Care, Pharmacists
Full-Text [PDF 438 kb]   (103 Downloads)    
Type of Study: Original Article | Subject: General
Received: 2022/11/24 | Accepted: 2023/05/8 | ePublished ahead of print: 2023/06/17 | Published: 2023/06/21
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadnezhad G, Jafari M, Esmaily H. Pharmacist Intervention in Controlling Symptoms with Common Upper Respiratory Disease. Iran J Cult Health Promot 2023; 7 (1) :68-74
URL: http://ijhp.ir/article-1-648-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 7, Issue 1 (Spring 2023) Back to browse issues page
نشريه فرهنگ و ارتقاء سلامت Iranian Journal of Culture and Health Promotion
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Persian site map - English site map - Created in 0.06 seconds with 38 queries by YEKTAWEB 4645